2025-521315-39-00RecruitingPhase 1
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 86 (estimated)
- First submitted
- 2 Jul 2025
- Start date
- 5 Nov 2025
- Lead sponsor
- Grey Wolf Therapeutics Limited
- Diseases
- Ankylosing spondylitis
- EU CT number
- 2025-521315-39-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 86
- 9 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with axial spondyloarthritis. The record gives no further details.
- Age
- 18 years or older
- Sex
- All sexes can join
Read by machine on 9 Nov 2026.
Sites (9)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Gent | Gent | Belgium | Recruiting |
| UZ Leuven | Leuven | Belgium | Recruiting |
| St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr | Herne | Germany | Recruiting |
| Hospital Universitario Reina Sofia | Córdoba | Spain | Not yet recruiting |
| Hospital Universitario La Paz | Madrid | Spain | Not yet recruiting |
| Parc Tauli Hospital Universitari | Sabadell | Spain | Not yet recruiting |
| Amsterdam UMC Stichting | Amsterdam | Netherlands | Recruiting |
| ETG Lublin Sp. z o.o. | Lublin | Poland | Recruiting |
| Reumedika Sp. z o.o. | Poznan | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.